title: Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid.
authors.affiliation: Department of Pediatrics, University of Jena, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Sauer
authors.forename: B
authors.initials: B
authors.lastname: Gruhn
authors.forename: D
authors.initials: D
authors.lastname: Fuchs
authors.forename: W W
authors.initials: WW
authors.lastname: Altermann
authors.forename: A
authors.initials: A
authors.lastname: Greinacher
authors.forename: H
authors.initials: H
authors.lastname: Völpel
authors.forename: F
authors.initials: F
authors.lastname: Zintl
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000276:immunology*; D016026:Bone Marrow Transplantation; D002809:Chondroitin Sulfates / Q000276:immunology*; D003871:Dermatan Sulfate / Q000276:immunology*; D004338:Drug Combinations; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects; D006496:Heparinoids / Q000276:immunology*; D006497:Heparan Sulfate / Q000276:immunology*; D024764:Hirudin Therapy; D006801:Humans; D011486:Protein C / Q000378:metabolism*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D005343:Fibrinolytic Agents; D006493:Heparin; D006496:Heparinoids; D006497:Heparan Sulfate; D011486:Protein C; D011994:Recombinant Proteins; C035838:danaparoid